These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 7940916)
1. Isolation and identification of two cyclosporine aldehydic metabolites from the bile of a liver transplant recipient during an acute nephrotoxic episode. Duncan S; Liu WT; Levy GA; Skorecki K; Pang H; Wong PY Transplant Proc; 1994 Oct; 26(5):2899-901. PubMed ID: 7940916 [No Abstract] [Full Text] [Related]
3. Long-term effect of cyclosporine on renal function in children after liver transplantation. Bilik R; Superina RA; Hu X Transplant Proc; 1993 Aug; 25(4):2578-9. PubMed ID: 8356677 [No Abstract] [Full Text] [Related]
4. Measurement of AM19 and other cyclosporine metabolites in the blood of liver transplant patients with stable liver function. Liu WT; Levy GA; Wong PY Ther Drug Monit; 1995 Oct; 17(5):479-86. PubMed ID: 8585111 [TBL] [Abstract][Full Text] [Related]
5. Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation. Avolio AW; Agnes S; Nanni G; Citterio F; Magalini SC; Castagneto M Transplant Proc; 1991 Aug; 23(4):2221-2. PubMed ID: 1871853 [No Abstract] [Full Text] [Related]
6. A comparison of azathioprine and cyclosporine in liver transplantation: a study of two personal series. Krom RA; Wiesner RH; Haagsma EB; Ludwig J; Gips CH; Grond AJ; Houthoff HJ Transplant Proc; 1987 Feb; 19(1 Pt 3):2440-2. PubMed ID: 3079085 [No Abstract] [Full Text] [Related]
7. Use of cyclosporine with poor initial renal function results in severely diminished renal clearance up to three years following liver transplantation. Cooper JL; Wahlstrom E; Anderson J; Schwerman L; Poterucha J; Krom RA Transplant Proc; 1991 Feb; 23(1 Pt 2):1489-91. PubMed ID: 1989274 [No Abstract] [Full Text] [Related]
8. Balancing cyclosporine A nephrotoxicity and rejection late after adult liver transplantation. Paul A; Levy GA; Greig PD Transplant Proc; 1993 Aug; 25(4):2664-5. PubMed ID: 8356714 [No Abstract] [Full Text] [Related]
9. Prevention of graft failure by hyperalimentation-induced intracellular glycogen storage in swine liver transplantation. Sadamori H; Tanaka N; Orita K Transplant Proc; 1994 Aug; 26(4):2253-7. PubMed ID: 8066741 [No Abstract] [Full Text] [Related]
10. Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients. Tchervenkov JI; Tector AJ; Cantarovich M; Tahta SA; Asfar A; Naimi J; Elias N; Barkun J Transplant Proc; 1996 Aug; 28(4):2247-9. PubMed ID: 8769214 [No Abstract] [Full Text] [Related]
11. Cyclosporine and bilirubin metabolites compete for the hepatic excretory system. Kohlhaw K; Christians U; Sürig T; Lamesch P; Hauss J; Sewing KF; Pichlmayr R Transplant Proc; 1994 Oct; 26(5):2798-9. PubMed ID: 7940880 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics of cyclosporine: binding of cyclosporine in bile. Mraz W; Graf A Transplant Proc; 1994 Aug; 26(4):1920. PubMed ID: 8066625 [No Abstract] [Full Text] [Related]
14. Absorption of cyclosporine Neoral early after liver transplantation: influence of bile on oral absorption. Oldhafer K; Haller GW; Kattner A; Winkler M; Maibücher A; Färber L; Bechstein WO; Ringe B; Neuhaus P; Pichlmayr R Transplant Proc; 1996 Aug; 28(4):2237-8. PubMed ID: 8769210 [No Abstract] [Full Text] [Related]
15. Nature of the toxicity of cyclosporin A in the rat. Farthing MJ; Clark ML Biochem Pharmacol; 1981 Dec; 30(24):3311-6. PubMed ID: 7326039 [No Abstract] [Full Text] [Related]
16. Hepatocyte transplantation into spleen or solid supports: comparison of morphology, function, and proliferative response. Borel Rinkes IH; Bijma A; Sinaasappel M; Terpstra OT Transplant Proc; 1993 Feb; 25(1 Pt 2):1014-6. PubMed ID: 8442025 [No Abstract] [Full Text] [Related]
17. Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats. Azzadin A; Małyszko J; Małyszko JS; Tankiewicz A; Myśliwiec M; Buczko W Pol J Pharmacol; 2002; 54(5):469-73. PubMed ID: 12593533 [TBL] [Abstract][Full Text] [Related]
18. Following-up of a four-dose daclizumab induction therapy without calcineurin inhibitors in a liver transplantation recipient with severe renal dysfunction: a case report. Zhang Y; Wen T; Yan L; Chen Z; Li B; Zeng Y Transplant Proc; 2008 Dec; 40(10):3819-20. PubMed ID: 19100502 [TBL] [Abstract][Full Text] [Related]
19. The significance of local immunosuppression in canine liver transplantation. Ko S; Nakajima Y; Kanehiro H; Taki J; Aomatsu Y; Yoshimura A; Yagura K; Kin T; Ohashi K; Nakano H Transplantation; 1994 Jun; 57(12):1818-21. PubMed ID: 8016890 [No Abstract] [Full Text] [Related]
20. Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. Park KM; Hay JE; Lee SG; Lee YJ; Wiesner RH; Porayko MK; Krom RA Transplant Proc; 1996 Jun; 28(3):1738-40. PubMed ID: 8658863 [No Abstract] [Full Text] [Related] [Next] [New Search]